Down-regulation of MicroRNA-133 predicts poor overall survival and regulates the growth and invasive abilities in glioma

References

• Wu X, Hu A, Zhang M, et al. Effects of Rab27a on proliferation, invasion, and anti-apoptosis in human glioma cell. Tumor Biol. 2013;34:2195–2203.
   PubMed Web of Science ®Google Scholar
• Xu Y, Xu W, Lu T, et al. miR-126 affects the invasion and migration of glioma cells through GATA4. Artif Cells Nanomed Biotechnol. Forthcoming. [7 p.]. doi: 10.1080/21691401.2016.1226179
   Web of Science ®Google Scholar
• Liu Q, Liao F, Wu H, et al. Different expression of miR-29b and VEGFA in glioma. Artif Cells Nanomed Biotechnol. 2016;44:1927–1932.
   PubMed Web of Science ®Google Scholar
• Nieder C, Adam M, Molls M, et al. Therapeutic options for recurrent high-grade glioma in adult patients: recent advances. Crit Rev Oncol Hematol. 2006;60:181–193.
   PubMed Web of Science ®Google Scholar
• Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352:987–996.
   PubMed Web of Science ®Google Scholar
• Dou Y, Wang Y, Xu J, et al. Experiment research on inhibition of glioma with sTRAIL in vitro. Artif Cells Nanomed Biotechnol. 2014;42:186–191.
   PubMed Web of Science ®Google Scholar
• Jinling W, Sijing S, Jie Z, et al. Prognostic value of circulating microRNA-21 for breast cancer: a systematic review and meta-analysis. Artif Cells Nanomed Biotechnol. Forthcoming. [6 p.]. doi: 10.1080/21691401.2016.1216856
   Web of Science ®Google Scholar
• Xu XM, Qian JC, Deng ZL, et al. Expression of miR-21, miR-31, miR-96 and miR-135b is correlated with the clinical parameters of colorectal cancer. Oncol Lett. 2012;4:339–345.
   PubMed Web of Science ®Google Scholar
• Chen S, Dai Y, Zhang X, et al. Increased miR-449a expression in colorectal carcinoma tissues is inversely correlated with serum carcinoembryonic antigen. Oncol Lett. 2014;7:568–572.
   PubMed Web of Science ®Google Scholar
• Lu Z, Ye Y, Jiao D, et al. miR-155 and miR-31 are differentially expressed in breast cancer patients and are correlated with the estrogen receptor and progesterone receptor status. Oncol Lett. 2012;4:1027–1032.
   PubMed Web of Science ®Google Scholar
• Lei SL, Zhao H, Yao HL, et al. Regulatory roles of microRNA-708 and microRNA-31 in proliferation, apoptosis and invasion of colorectal cancer cells. Oncol Lett. 2014;8:1768–1774.
   PubMed Web of Science ®Google Scholar
• Luo J, Zhou J, Cheng Q, et al. Role of microRNA-133a in epithelial ovarian cancer pathogenesis and progression. Oncol Lett. 2014;7:1043–1048.
   PubMed Web of Science ®Google Scholar
• Wu J, Cui H, Zhu Z, et al. MicroRNA-200b-3p suppresses epithelial-mesenchymal transition and inhibits tumor growth of glioma through down-regulation of ERK5. Biochem Biophys Res Commun. 2016;478:1158–1164.
   PubMed Web of Science ®Google Scholar
• Wei J, Wang F, Kong LY, et al. miR-124 inhibits STAT3 signaling to enhance T cell-mediated immune clearance of glioma. Cancer Res. 2013;73:3913–3926.
   PubMed Web of Science ®Google Scholar
• Wang Z, Dai X, Chen Y, et al. miR-30a-5p is induced by Wnt/β-catenin pathway and promotes glioma cell invasion by repressing NCAM. Biochem Biophys Res Commun. 2015;465:374–380.
   PubMed Web of Science ®Google Scholar
• Cai JJ, Qi ZX, Chen LC, et al. miR-124 suppresses the migration and invasion of glioma cells in vitro via Capn4. Oncol Rep. 2016;35:284–290.
   PubMed Web of Science ®Google Scholar
• An L, Liu Y, Wu A, et al. microRNA-124 inhibits migration and invasion by down-regulating ROCK1 in glioma. PLoS One. 2013;8:e69478.
   PubMed Web of Science ®Google Scholar
• Yang Y, Wu J, Guan H, et al. MiR-136 promotes apoptosis of glioma cells by targeting AEG-1 and Bcl-2. FEBS Lett. 2012;586:3608–3612.
   PubMed Web of Science ®Google Scholar
• Li Z, Liu YH, Diao HY, et al. MiR-661 inhibits glioma cell proliferation, migration and invasion by targeting hTERT. Biochem Biophys Res Commun. 2015;468:870–876.
   PubMed Web of Science ®Google Scholar
• Wu J, Cui H, Zhu Z, et al. MicroRNA-200b-3p suppresses epithelial–mesenchymal transition and inhibits tumor growth of glioma through down-regulation of ERK5. Biochem Biophys Res Commun. 2016;478:1158–1164.
   PubMed Web of Science ®Google Scholar
• Xu W, Liu M, Peng X, et al. miR-24-3p and miR-27a-3p promote cell proliferation in glioma cells via cooperative regulation of MXI1. Int J Oncol. 2013;42:757–766.
   PubMed Web of Science ®Google Scholar
• Wu N, Zhao X, Liu M, et al. Role of microRNA-26b in glioma development and its mediated regulation on EphA2. PLoS One. 2011;6:e16264.
   PubMed Web of Science ®Google Scholar
• Ehrlund A, Anthonisen EH, Gustafsson N, et al. E3 ubiquitin ligase RNF31 cooperates with DAX-1 in transcriptional repression of steroidogenesis. Mol Cell Biol. 2009;29:2230–2242.
   PubMed Web of Science ®Google Scholar
• Liang CC, Park AY, Guan JL. In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc. 2007;2:329–333.
   PubMed Web of Science ®Google Scholar
• Zhu J, Zhao C, Zhuang T, et al. RING finger protein 31 promotes p53 degradation in breast cancer cells. Oncogene. 2016;35:1955–1964.
   Google Scholar
• Micale L, Fusco C, Fontana A, et al. TRIM8 downregulation in glioma affects cell proliferation and it is associated with patients survival. BMC Cancer. 2015;15:470.
   PubMed Web of Science ®Google Scholar
• Fakhoury M. Drug delivery approaches for the treatment of glioblastoma multiforme. Artif Cells Nanomed Biotechnol. 2016;44:1365–1373.
   PubMed Web of Science ®Google Scholar
• Chen W, Yang Y, Chen B, et al. MiR-136 targets E2F1 to reverse cisplatin chemosensitivity in glioma cells. J Neurooncol. 2014;120:43–53.
   PubMed Web of Science ®Google Scholar
• Cheng Z, Liu F, Wang G, et al. miR-133 is a key negative regulator of CDC42-PAK pathway in gastric cancer. Cell Signal. 2014;26:2667–2673.
   PubMed Web of Science ®Google Scholar
• Zhang XT, Zhang Z, Xin YN, et al. Impairment of growth of gastric carcinoma by miR-133-mediated Her-2 inhibition. Tumor Biol. 2015;36:8925–8930.
   PubMed Web of Science ®Google Scholar
• Song X, Shi B, Huang K, et al. miR-133a inhibits cervical cancer growth by targeting EGFR. Oncol Rep. 2015;34:1573–1580.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Wu D, Tao J, et al. MicroRNA-133 inhibits cell proliferation, migration and invasion by targeting epidermal growth factor receptor and its downstream effector proteins in bladder cancer. Scand J Urol. 2013;47:423–432.
   PubMed Web of Science ®Google Scholar
• Tao J, Wu D, Xu B, et al. microRNA-133 inhibits cell proliferation, migration and invasion in prostate cancer cells by targeting the epidermal growth factor receptor. Oncol Rep. 2012;27:1967–1975.
   PubMed Web of Science ®Google Scholar
• Myatt SS, Lam EW. The emerging roles of forkhead box (Fox) proteins in cancer. Nat Rev Cancer. 2007;7:847–859.
   PubMed Web of Science ®Google Scholar
• Jin Y, Han B, Chen J, et al. FOXC1 is a critical mediator of EGFR function in human basal-like breast cancer. Ann Surg Oncol. 2014;21:S758–S766.
   PubMed Web of Science ®Google Scholar
• Xu Y, Shao QS, Yao HB, et al. Overexpression of FOXC1 correlates with poor prognosis in gastric cancer patients. Histopathology. 2014;64:963–970.
   PubMed Web of Science ®Google Scholar
• Wei LX, Zhou RS, Xu HF, et al. High expression of FOXC1 is associated with poor clinical outcome in non-small cell lung cancer patients. Tumor Biol. 2013;34:941–946.
   PubMed Web of Science ®Google Scholar
• Chung TK, Lau TS, Cheung TH, et al. Dysregulation of microRNA-204 mediates migration and invasion of endometrial cancer by regulating FOXC1. Int J Cancer. 2012;130:1036–1045.
   PubMed Web of Science ®Google Scholar
• Yu C, Wang M, Li Z, et al. MicroRNA-138-5p regulates pancreatic cancer cell growth through targeting FOXC1. Cell Oncol (Dordr). 2015;38:173–181.
   PubMed Web of Science ®Google Scholar